Store
UCB Pharma S.A.
Braine-L'Alleud Feb 2022 483R

483RFeb 4, 2022

483R Document: UCB Pharma S.A.

Wayne E. Seifert, FDA Investigator Roger F. Zabinski, FDA Investigator

FDANews 483R UCB Pharma S.A. Feb 4 2022 top

Wayne E. Seifert FDA Investigator Roger F. Zabinski FDA Investigator

FDA inspected UCB Pharma S.A.'s Braine-L'Alleud site on Feb 04, 2022. See how they responded.